BioSpace News Archive

U.S. FDA Approves Takeda’s ALUNBRIG ® (brigatinib) as a First-Line Treatment Option for Patients Diagnosed with Rare and Serious Form of Lung Cancer − Long-Term Results from the Phase 3 ALTA 1L Trial Established ALUNBRIG as a Superior First-Line Treatment Compared to Crizotinib for People with ALK+ Metastatic NSCLC, Including those with Brain Metastases CAMBRIDGE, Mass. & OSAKA, Japan--( BUSINESS WIRE )-- Takeda Pharmaceutical Company Limited (

California based Best Chance Products, LLC announced that BioCore Co., Ltd., a South Korean manufacturer of 2019 nCoV Real Time PCR Test Kits, has named it the exclusive distributor of BioCore’s COVID-19 Tests in the United States.

Pooled data from two pivotal Phase III open-label extension (OLE) studies show satralizumab was well-tolerated as a monotherapy or in combination with baseline immunosuppressive therapy in people with neuromyelitis optica spectrum disorder (NMOSD)

According to the report, the global ultrasound gels market was valued at ~US$ 310 Mn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027.

Transparency Market Research has published a new report titled, “Implantable loop recorders market”.

The global diabetic ulcers treatment market was valued at approximately US$ 7.3 Bn in 2017.

According to the report, the global collagen dressings market was valued at ~US$ 926 Mn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030.

Over the past few years, the market for aesthetic services has witnessed a surge in research activities.

Laboratory may refer to a type of facility where controlled conditions are provided to carry out technological or scientific research, measurements, and different experiments.

Tiziana Life Sciences plc announces that it intends to demerge its StemPrintER and SPARE genomics-based personalized medicine businesses into a separate company and effect a capital reduction to facilitate the spin-out and listing of StemPrintER as an independent entity.